Advantages And Disadvantages of Different COVID-19 Vaccines
DOI:
https://doi.org/10.54097/hset.v45i.7483Keywords:
COVID-19, Vaccines, Advantages.Abstract
After the outbreak of the epidemic, countries around the world have begun intensive research and development of vaccines. Theoretically, all existing vaccine types and technologies can be applied to COVID-19 vaccine research. More than 100 COVID-19 vaccine projects registered on the official website of WHO include these three generations of different types of vaccines. At present, 16 vaccines have entered clinical trials, five of which are from China, including two inactivated vaccines under China Biotechnology Co., Ltd. (hereinafter referred to as "China Biotechnology"). Most of these vaccines are still in phase I. This article will introduce inactivated vaccine, Ad5-nCoV Adenovirus vector COVID-19 vaccine, RBD CHO vaccine and nucleic acid vaccine in detail. The different vaccines have different advantages due to the different ways of working. At the moment when the COVID-19 vaccine has been launched, personal protection and cutting off the transmission route of COVID-19 are still the most important ways to protect oneself and prevent the spread of the epidemic.
Downloads
References
Liao Pan, Xiao Yijun. Overview of research and development strategy and progress of COVID-19 vaccine [J]. Biology Teaching, 2021 (5): 8-10
Working principle of inactivated vaccine [J]. China Sugar Beet Industry, 2021 (3): 40-40
Guo Li, Wang Jianwei, Hong Tao. Research progress in molecular biology of coronavirus] J]
Journal of Virology, 2003, 19 (4): 376-380
Zhang Zhuoping. How much do you know about COVID-19 vaccine [J]. Science Examination for Middle School Students, 2022 (3): 49-51
Chen Ze. Thoughts on the research and development of COVID-19 vaccine [J]. Life Science Research, 2020 (4): 259-262
Shen Mei, Chen Bingqing, Yu Ruisong, et al. The structure of coronavirus S protein and its receptor
Structure and function [J]. Microbiology Bulletin, 2017, 44 (10): 2452 - 2462
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021 Oct;21(10):626-636. doi: 10.1038/s41577-021-00592-1. Epub 2021 Aug 9. PMID: 34373623; PMCID: PMC8351583.
Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. [Comment] COVID 19 vaccine safety. Int J Mol Med. 2020 Nov;46(5):1599-1602. doi: 10.3892/ijmm.2020.4733. Epub 2020 Sep 18. PMID: 33000193; PMCID: PMC7521561.
Yang Anna, Wang Yin, Yang Dongsheng, et al. novel coronavirus inactivated vaccine (Vero cell) β- Establishment, optimization and validation of a gas chromatographic method for the determination of propanolactone residues [J]. Chinese Journal of Biological Products, 2021 (4): 448-452
This journal is comprehensive. One shot, two shots, three shots and COVID-19 vaccine have their own characteristics [J]. Invention and innovation: Big Science and Technology, 2021 (6): 54-54
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







